Model Aa-2012

Aerospace Accessory Service
Human Otc Drug
NDC 27860-014

Model Aa-2012 is a human otc drug labeled by 'Aerospace Accessory Service'. National Drug Code (NDC) number for Model Aa-2012 is 27860-014. This drug is available in dosage form of Kit. The names of the active, medicinal ingredients in Model Aa-2012 drug includes . The currest status of Model Aa-2012 drug is Active.

Drug Information:

Drug NDC:	27860-014
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name:	Model Aa-2012
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type:	Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name:	Model Aa-2012
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name:	Aerospace Accessory Service
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form:	Kit
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status:	Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.

Marketing Category:	UNAPPROVED DRUG OTHER
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date:	01 Jun, 2022
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date:	05 May, 2026
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date:	31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.

Manufacturer Name:	AEROSPACE ACCESSORY SERVICE
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
RxCUI:	1038558
The RxNorm Concept Unique Identifier. RxCUI is a unique number that describes a semantic concept about the drug product, including its ingredients, strength, and dose forms.
Original Packager:	Yes
Whether or not the drug has been repackaged for distribution.
UPC:	0616784130323
UPC stands for Universal Product Code.
UNII:
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDC	Description	Marketing Start Date	Marketing End Date	Sample Available
27860-014-01	1 KIT in 1 KIT (27860-014-01) * 2.6 g in 1 PACKET (68356-126-02) * 100 PACKET in 1 BOX (67777-245-01) / .55 mL in 1 PACKET	01 Jun, 2022	N/A	No
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Other medicines with the same generic name

Model Aa-2012

Kit
AEROSPACE ACCESSORY SERVICE
NDC: 27860-014

Purpose:

Antiseptic wipes purpose first aid antiseptic

Bzk pads purpose first aid antiseptic

Product Elements:

Model aa-2012 model aa-2012 loris bzk antiseptic wipes benzalkonium chloride water benzalkonium chloride benzalkonium bzk pads benzalkonium chloride methylchloroisothiazolinone/methylisothiazolinone mixture water benzalkonium chloride benzalkonium

Indications and Usage:

Antiseptic wipes uses first aid antiseptic

Bzk pads uses first aid to help prevent skin infection in minor cuts, scrapes and burns

Warnings:

Antiseptic wipes warnings for external use only do not use do not use it in the eyes or apply over large areas of the body. in case of deep or puncture wounds, animal bites, or serious burns, consult a doctor. stop use and consult a doctor if the condition persists or gets worse. do not use it for longer than 1 week unless directed by a doctor. antiseptic wipes keep out of reach of children if swallowed, get medical help or contact a poison control center right away.

Bzk pads warnings for external use only do not use as an antiseptic for more than 1 week in the eyes ask a doctor before use if you have deep puncture wounds, animal bites, or serious burns stop use and ask a doctor if irritation or redness develop condition persistor gets worse keep out of reach of children if swallowed get medical help or contact a poison control center ( 1-800-222-1222) right away

Do Not Use:

Dosage and Administration:

Antiseptic wipes directions tear open pouch and use as part of your daily cleansing routine. clean the affected area. apply this product on the area 1 to 3 times daily. may be covered with a sterile bandage. if bandaged, let dry first.

Bzk pads directions clean the affected area may be covered with a sterile bandage if bandaged, let dry first

Stop Use:

Stop use and ask a doctor if irritation or redness develop condition persistor gets worse

Package Label Principal Display Panel:

Antiseptic wipes principal display panel label

Bzk pads principal display panel label

Model aa-2012 label

Further Questions:

Antiseptic wipes questions call 1-866-322-4634, weekdays between 8:00 am and 6:00 pm est

Bzk pads questions 1-800-dynarex monday-friday 9am-5pm est

Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.